FindMyKOL
Clinical trialNCT01864928CompletedObservational

Rapid Evaluation for Stroke Outcomes Using Lytics in Vascular Event (RESOLVE) Registry and Implementation Quality Improvement Study

NCT01864928 is an observational study sponsored by Saint Luke's Health System. As of 21 Nov 2026, it is completed. It studies Acute Ischemic Stroke. The registry lists an enrollment of 192 participants. The registry lists a start date of 31 Jul 2013 and a primary completion date of 31 Dec 2016. One of its registered investigators has a FindMyKOL profile.

SponsorSaint Luke's Health System →Enrollment192Acute Ischemic Stroke
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT01864928
FieldValue
Registry IDNCT01864928
StatusCompleted
Study typeObservational study
Lead sponsorSaint Luke's Health System
Enrollment192
ConditionsAcute Ischemic Stroke
Start31 Jul 2013
Primary completion31 Dec 2016
Study completion31 Dec 2016
Last update posted19 Oct 2021

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Despite abundant evident supporting the use of acute reperfusion therapy in the setting of acute ischemic stroke (AIS), adoption of this practice in routine clinical care is poor. We hypothesize that a significant barrier is the difficulty in weighing the benefits and risks of rt-PA treatment in the care of an individual patient, a problem compounded by the time urgency of decision-making and clinical fears that weigh risks of treatment more heavily than benefits. The goal of this Quality Improvement (QI) study is to leverage an IT solution that we have developed, ePRISM, that executes multivariable risk models with patient-specific data so that a personalized estimate of an individual's outcomes (both risks and benefits) with and without rt-PA, can be generated so support safer, more effective clinical care. Through an earlier project, we will have programmed ePRISM with the best available risk-stratification models and developed a clinically useful format for presenting the data to support clinical decision-making in AIS. Through QI, we propose to identify the optimal mechanism for integrating the tool within the routine flow of patient care in preparation for more definitive studies, or dissemination strategies, to improve the treatment of patients with AIS.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

No facility list is in our current data snapshot for this study. The registry record on ClinicalTrials.gov ↗ carries any published locations. Why? →

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT01864928

Each answer restates registry values shown on this page.

What is NCT01864928?

NCT01864928 is an observational study sponsored by Saint Luke's Health System. It studies Acute Ischemic Stroke.

Who leads NCT01864928?

The registry names Carole Decker, MSN, PhD (study director, St. Luke's Hospital, Kansas City, Missouri) and John A Spertus, MD, MPH (principal investigator, St. Luke's Hospital, Kansas City, Missouri) as overall officials.

When did NCT01864928 end?

The registry lists a primary completion date of 31 Dec 2016 and a study completion date of 31 Dec 2016. The sponsor last updated the record on 19 Oct 2021.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.